Skip to main content
Skip to section navigation
Skip to footer
Bioscience
Bioscience
Obesity
Our Company
Pipeline
Media & Investors
Contact
Investors
News
Company Info
Highlights
Corporate Presentation
IR Calendar/Webcasts
Executive Team
Email Alerts
Contacts
FAQ
Spotlight
Financial Info
Overview
Financial Results
Income Statement
Balance Sheet
Cash Flow
Stock Data
Analyst Coverage
Quote and Chart
Historical Data
SEC Filings
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Overview
Board of Directors
Board Committees
Back to CorporateSite.com
All SEC Filings
Investors
Investors
Investors
News
Company Info
Highlights
Corporate Presentation
IR Calendar/Webcasts
Executive Team
Email Alerts
Contacts
FAQ
Spotlight
Financial Info
Overview
Financial Results
Income Statement
Balance Sheet
Cash Flow
Stock Data
Analyst Coverage
Quote and Chart
Historical Data
SEC Filings
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Overview
Board of Directors
Board Committees
Filing Type
View All
10-K
10-K/A
10-Q
10-Q/A
144
3
3/A
4
4/A
424B2
424B3
424B4
424B5
5
8-A12B
8-A12G
8-K
8-K/A
AW
CERT
CORRESP
CT ORDER
D
D/A
DEF 14A
DEF 14C
DEFA14A
DEFM14A
EFFECT
POS AM
PRE 14A
PRE 14C
PREM14A
S-1
S-1/A
S-1MEF
S-3
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC 14F1
SCHEDULE 13D/A
SEC STAFF LETTER
UPLOAD
Year
View All
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
SEC Filings
Date
Form
Description
XBRL
Pages
04/09/24
CORRESP
Form CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
1
04/04/24
S-1/A
Form S-1/A: General form of registration statement for all companies including face-amount certificate companies
53
04/03/24
8-K
Form 8-K: Current report filing
6
04/02/24
UPLOAD
Form UPLOAD: SEC-generated letter
1
03/27/24
S-1
Form S-1: General form of registration statement for all companies including face-amount certificate companies
169
03/27/24
D
Form D: Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(a)(5) under the Act.
5
03/22/24
10-K
Form 10-K: Annual report pursuant to Section 13 and 15(d)
227
03/15/24
4
Form 4: Statement of changes in beneficial ownership of securities
1
03/15/24
4
Form 4: Statement of changes in beneficial ownership of securities
3
03/13/24
SC 13D/A
Form SC 13D/A: Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities
11
rss_feed
Filing RSS
Previous Page
arrow_back
Page
1
…
Page
3
Page
4
Page
5
Page
6
Page
7
Page
8
Page
9
Page
10
Page
11
Page
12
…
Page
54
Next Page
arrow_forward
Select a page
Page 1
Page 2
Page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Page 9
Page 10
Page 11
Page 12
Page 13
Page 14
Page 15
Page 16
Page 17
Page 18
Page 19
Page 20
Page 21
Page 22
Page 23
Page 24
Page 25
Page 26
Page 27
Page 28
Page 29
Page 30
Page 31
Page 32
Page 33
Page 34
Page 35
Page 36
Page 37
Page 38
Page 39
Page 40
Page 41
Page 42
Page 43
Page 44
Page 45
Page 46
Page 47
Page 48
Page 49
Page 50
Page 51
Page 52
Page 53
Page 54
email
Email Alerts
location_city
Company Profile
contact_page
Contacts
account_tree
Sitemap